Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, October 2001, p. 2958-2960, Vol. 45, No. 10
Dipartimento di Scienze Microbiologiche e
Scienze Ginecologiche1 and Dipartimento
di Biologia Animale,2 Università degli
Studi, Catania, Italia
Received 12 March 2001/Returned for modification 17 April
2001/Accepted 20 July 2001
We describe two mutants of Mycoplasma hominis PG-21
which show resistance to 16-membered macrolides but susceptibility to lincosamides, obtained by in vitro exposure to increasing doses of
josamycin. The 23S rRNA gene showed that each had a mutation (A2062G
and A2062T) corresponding to nucleotide 2062 in Escherichia coli, which was associated with the acquired phenotype.
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.10.2958-2960.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Two New Point Mutations at A2062 Associated with
Resistance to 16-Membered Macrolide Antibiotics in Mutant Strains of
Mycoplasma hominis
*
Corresponding author. Mailing address: Dipartimento di
Scienze Microbiologiche e Scienze Ginecologiche, Università di
Catania, Via Androne 81, 95124 Catania, Italy. Phone: 39 095316038. Fax: 39 095312798. E-mail: furneri{at}mbox.unict.it.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |